Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 530871 | NSE Symbol : CHEMBOND | ISIN : INE995D01025 | Industry : Chemicals |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
24-Apr-2025	24-Apr-2025	Scheme of Arrangement	Outcome of Board Meeting - Effectiveness of the Composite Scheme of Arrangements ('Scheme')
16-Jan-2025	24-Jan-2025	Quarterly Results	CHEMBOND CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 inter alia to consider and approve Pursuant to the provisions of Regulation 29 and other applicable regulations if any of the SEBI (LODR) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Friday 24th January 2025 inter-alia to consider approve and take on record the Unaudited Financial Results on Standalone and Consolidated basis for the quarter and nine months ended 31st December 2024 (Q3). Further pursuant to our letter Ref. No. SE/CS/2024-25/52 dated 27th December 2024 and in terms of SEBI (PIT) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of board meeting i.e. till Sunday 26th January 2025. In continuation to our letter bearing Ref. no. SE/CS/2024-25/56 dated 16th January, 2025, and pursuant to Regulation 33, 30 and other applicable regulations, if any, of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in its meeting held today considered and approved the Unaudited Financial Results (Standalone and Consolidted) for the quarter and nine months ended 31st December, 2024 which are enclosed, along with the Limited Review Report. The meeting of Audit Committee/ Board of Directors of the Company commenced at 10.45 a.m. and concluded at 2 p.m. (As Per BSE Announcement Dated on: 24/01/2025)
17-Oct-2024	25-Oct-2024	Quarterly Results	CHEMBOND CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve Pursuant to the provisions of Regulation 29 and other applicable regulations if any of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Friday 25th October 2024 inter-alia to consider approve and take on record the Unaudited Financial Results on Standalone and Consolidated basis for the quarter and half year ended 30th September 2024 (Q2). Further pursuant to our letter Ref. No. SE/CS/2024-25/39 dated 25th September 2024 and in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of board meeting i.e. till Sunday 27th October 2024. In continuation to our letter bearing Ref. no. SE/CS/2024-25/43 dated 17th October, 2024, and pursuant to Regulations 33, 30 of SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in its meeting held today considered and approved inter alia: 1. the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2024 which are enclosed, along with the Limited Review Report; 2. the Notice convening the Meeting of the Equity Shareholders of the Company to be held on Friday, 6th December, 2024 at 11:00 a.m. (IST) through Audio/ Video conferencing, pursuant to the directions of the Hon'ble NCLT, Mumbai Bench, vide Order dated 11th October, 2024. The notice of said meeting will be issued to the shareholders holding shares as on 25th October 2024 (Cut-off date). The meeting of Audit Committee / Board of Directors of the Company commenced at 10.15 a.m. and concluded at 1:40 pm. Read less.. In continuation to our letter bearing Ref. no. SE/CS/2024-25/43 dated 17th October, 2024, and pursuant to Regulation 33, 30 of SEBI(LODR), Regulations, 2015, we hereby inform you that the Board of Directors of the Company in its meeting held today considered and approved inter alia: 1. the Unaudited Financials Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2024 which are enclosed, along with the Limited Review Report. 2. the Notice convening the Meeting of the Equity Shareholders of the Company to be held on Friday, 6th December, 2024 at 11:00 a.m. (IST) through Audio/Video conferencing, pursuant to the directions of the NCLT, Mumbai Bench vide Order dated 11th October, 2024. The notice of the said meeting will be issued to shareholders holding shares as on 25th October, 2024. Read less.. (As Per BSE Announcement Dated on 25.10.2024)
18-Jul-2024	26-Jul-2024	Quarterly Results	CHEMBOND CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 inter alia to consider and approve Dear Sir/Madam Pursuant to the provisions of Regulation 29 and other applicable regulations if any of SEBI (LODR) Regulations 2015 we wish to inform you that meeting of Board of Directors of the company is scheduled to be held on Friday 26th July 2024 inter-alia to consider approve and take on record the Unaudited Financial Results on Standalone and Consolidated basis for the quarter ended 30th June 2024 (Q1). Further pursuant to our letter Ref. No. SE/CS/2024-25/18 dated 27th June 2024 and in terms of SEBI (PIT) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of Company till 48 hours post the outcome of the board meeting i.e. till 28th July 2024. In continuation to our letter bearing Ref. no. SE/CS/2024-25/28 dated 18th July, 2024, and pursuant to Regulations 33, 30 and other applicable regulations, if any, of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in its meeting held today considered and approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2024 which are enclosed, along with the Limited Review Report. The meeting of Audit Committee/Board of Directors of the Company commenced at 12.30 pm and concluded at 2.45 pm. Further, pursuant to our letter Ref. No. SE/CS/2024-25/18 dated 27th June, 2024 and in terms of SEBI (PIT) Regulations, 2015 and Company's internal code of conduct, for prevention of Insider Trading, the Trading window for dealing in securities of the Company will remain closed for Directors/ Officers/ Designated persons of the Company till 48 hours post outcome of Board meeting i.e. till 28th July, 2024. (As Per BSE Announcement dated on 26.07.2024)
16-May-2024	25-May-2024	Final Dividend	CHEMBOND CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulations if any of the SEBI(LODR) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday 25th May 2024 inter alia 1. Audited Financial Results on Standalone and Consolidated basis for the quarter /year ended 31st March 2024; 2. to recommend declaration of dividend for FY 2023-24 if any. Further pursuant to our letter Ref no. SE/CS/2023-24/63 dated 26th March 2024 and in terms of SEBI (PIT) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading Window for dealing in securities of the Company will remain closed for Directors / Officers/ Designated Persons of the Company till 48 hours post the outcome of Board Meeting i.e. till Monday 27th May 2024. The trading window shall re-open on 28th May 2024. Outcome of Board Meeting held on May 25, 2024. a) Considered and approved the Audited Financial Statements (Standalone and Consolidated) for the quarter / year ended 31st March 2024 along with the Auditors' Report. b) Recommended Dividend of Rs.3.50 (Rupees Three and Fifty Paise only) per equity share for the financial year ended 31st March, 2024 subject to the approval of the members in the ensuing Annual General Meeting (AGM). The dividend will be paid within 30 days from the date of approval by the members at the ensuing AGM of the Company. c) Based on the recommendation of the Nomination and Remuneration Committee, approved the appointment of Mr. Jayesh Prabhulal Shah (DIN:00138346) as an Additional (Non-Executive and Independent) Director of the Company w.e.f. 25th May, 2024 for a period of five years, subject to approval of the members of the Company in the ensuing General Meeting Dear Sir, Pursuant to Regulation 33, 30 and other applicable regulations, if any, of the SEBI LODR we would like to inform that the Board of Directors at its meeting held today: a. Considered and approved the Audited Financial Statements (Standalone and Consolidated) for the quarter / year ended 31st March 2024 along with the Auditor''s Report thereon. Further, we would like to inform you that Bathiya and Associates LLP, Chartered Accountants, Statutory Auditors have issued Audit Reports with unmodified opinion. b. Recommended dividend of Rs.3.50 (Rupees Three and Fifty Paise only) per Equity Share for the financial year ended 31st March, 2024 subject to the approval of the members in the ensuing AGM. c. Based on the recommendation of NRC, approved appointment of Mr. Jayesh Prabhulal Shah (DIN: 00138346) as an Additional (Non-executive and Independent) Director of the Company w.e.f. 25th May, 2024 (As per BSE Announcement Dated on 25/05/2024)
17-Jan-2024	25-Jan-2024	Quarterly Results	CHEMBOND CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 inter alia to consider and approve Pursuant to the provisions of Regulation 29 and other applicable regulations if any of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Thursday 25th January 2024 inter-alia to consider approve and take on record the Unaudited Financial Results on Standalone and Consolidated basis for the quarter and nine months ended 31st December 2023 (Q3). Further pursuant to our letter Ref. No. SE/CS/2023-24/49 dated 26th December 2023 and in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of board meeting i.e. till 27th January 2024. In continuation to our letter bearing ref. no. SE/CS/2023-24/54 dated 17th January, 2024 and pursuant to Regulations 33,30 and other applicable regulations, if any, of the SEBI(LODR), 2015, we hereby inform you that the Board of Directors of the Company in its meeting held today considered and approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2023 which are enclosed,along with the LRR. The meeting of Audit Committee/Board of Directors of the Company commenced at 10.45a.m. and concluded at 1.45 p.m. Further, pursuant ot our letter Ref. no. SE/CS/2023-24/49 dated 26th December, 2023 and in terms of SEBI(PIT) Regulations, 2015 and the Company''s internal code of conduct, for prevention of Insider Trading, the Trading Window for dealing in securities of the Company will remain closed for Directors/Officers/Designated persons of the Company till 48 hours post the outcome of Board meeting i.e. 27th January, 2024. (As per BSE Announcement Dated on 25/01/2024)
12-Dec-2023	12-Dec-2023	Scheme of Amalgamation	Chembond Chemicals Ltd has informed the Exchange regarding Board meeting held on December 12, 2023. Chembond Chemicals Ltd has informed the Exchange about Scheme of Arrangement
25-Oct-2023	04-Nov-2023	Quarterly Results	CHEMBOND CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 inter alia to consider and approve Pursuant to the provisions of Regulation 29 and other applicable regulations if any of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday 4th November 2023 inter-alia to consider approve and take on record the Unaudited Financial Results on Standalone and Consolidated basis for the quarter and half year ended 30th September 2023 (Q2). Further pursuant to our letter Ref. No. SE/CS/2023-24/35 dated 26th September 2023 and in terms of SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of board meeting i.e. till 6th November 2023. In continuation to our letter bearing Ref. no. SE/CS/2023-24/40 dated 25th October, 2023 & pursuant to Regulations 33, 30 & other applicable regulations, if any, of SEBI (LODR), 2015, we hereby inform you that the Board of Directors of the Company in its meeting held today considered & approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter & half year ended 30th September, 2023 which are enclosed, along with the Limited Review Report. The meeting of Audit Committee / Board of Directors of the Company commenced at 10.15 a.m. & concluded at 02.30 p.m. Further, pursuant to our letter Ref. No. SE/CS/2023-24/35 dated 26/09/2023 & in terms of SEBI PIT Regulations, 2015 & the Company's internal code of conduct, for prevention of Insider Trading, the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of Board meeting i.e. till 6/11/2023. In continuation to our letter bearing Ref no. SE/CS/2023-24/40 dated 25th October 2023 & pursuant to Regulations 33, 30 and other applicable regulations, if any, of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in its meeting held today considered and approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2023 which are enclosed, along with Limited Review Report. The meeting of Audit Committee / Board of Directors of the Company commenced at 10.15 am and concluded at 2.30 pm. Trading window for dealing in securities of the Company will remain closed for Directors /Officers / Designated Persons of the Company till 48 hours post the outcome of Board Meeting i.e. 6th November, 2023. (As Per BSE Announcement Dated on 04.11.2023) In furtherance to our letter dated 6th November, 2023, with reference to captioned subject, please find enclosed herewith the newspaper cutting of Corrigendum published in the Marathi newspaper Mumbai Lakshadeep on 7th November, 2023. With reference to Unaudited Financial Results published in Mumbai Lakshadeep (Marathi) newspaper on 6th November, 2023, Board Meeting date for approval of Consolidated Unaudited Financial Results for quarter and half year ended 30th September, 2023 was inadvertently mentioned as 4th September, 2023 instead of 4th November, 2023 and Total Comprehensive Income for the period as on half year ended 30th September, 2022 was inadvertently mentioned as 645.45 instead of 645.65 and Chairman and Managing Director was inadvertently mentioned as Vice- Chairman and Managing Director. (As Per BSE Announcement Dated on 07.11.2023)
04-Aug-2023	12-Aug-2023	Quarterly Results	CHEMBOND CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve Pursuant to the provisions of Regulation 29 and other applicable regulations if any of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday 12th August 2023 inter-alia to consider approve and take on record the Unaudited Financial Results on Standalone and Consolidated basis for the quarter ended 30th June 2023 (Q1). Further pursuant to our letter Ref. No. SE/CS/2023-24/16 dated 29th June 2023 and in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of board meeting i.e. till 14th August 2023. In continuation to our letter bearing Ref. no. SE/CS/2023-24/25 dated 4th August, 2023, and pursuant to Regulations 33, 30 & other applicable regulations, if any, of the SEBI (LODR), 2015, we hereby inform you that the Board of Directors of the Company in its meeting held today considered and approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2023 which are enclosed, along with the Limited Review Report. The meeting of Audit Committee / Board of Directors of the Company commenced at 10.15 a.m. and concluded at 12.30 p.m. Further, pursuant to our letter Ref. No. SE/CS/2023-24/16 dated 29th June, 2023 and in terms of SEBI (PIT) Regulations, 2015 and the Company's internal code of conduct, for prevention of Insider Trading, the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of Board meeting i.e. till 14th August, 2023. In continuation to our letter bearing ref no. SE/CS/2023-24/25 dated 4th August, 2023 and pursuant to Regulations 33, 30 and other applicable Regulations, if any of the SEBI (LODR), 2015, we hereby informed you that the Board of Directors of the Company in its meeting held today considered and approved the Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended 30th June, 2023 which are enclosed along with the Limited Review Report. (As per BSE Announcement Dated on 12/08/2023)
11-May-2023	20-May-2023	Accounts	CHEMBOND CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2023 inter alia to consider and approve Pursuant to the provisions of Regulation 29 and other applicable regulations if any of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday 20th May 2023 inter-alia ? to consider approve and take on record the Audited Financial Results on Standalone and Consolidated basis for the quarter / year ended 31st March 2023; ? to recommend declaration of dividend for FY 2022-23 if any. Further pursuant to our letter Ref. No. SE/CS/2022-23/55 dated 30th March 2023 and in terms of SEBI (PIT) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of board meeting i.e. till 22nd May 2023. The Trading window shall re-open on 23rd May 2023. Pursuant to Regulations 33, 30 and other applicable regulations, if any, of SEBI LODR, we would like to inform you that the Board of Directors of the Company at its meeting held today: a) Considered and approved the Audited Financial Statement (Standalone and Consolidated) for the quarter / year ended 31st March 2023 which are enclosed herewith along with the Auditors' Report on the Standalone and Consolidated Financial Statement. Bathiya & Associates, LLP, Statutory Auditors have issued Audit Reports with unmodified opinion on the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2023. b) Recommended Dividend of Rs.3.00 per equity share for the fy ended 31st March, 2023 subject to the approval of the members in the ensuing AGM. c) Re-appointed M/s. Bathiya and Associates LLP (Firm Registration No. 101046W/W100063) as Statutory Auditors of the Company for a term of five years, subject to approval of members at the ensuing AGM. (As Per BSE Announcement Dated on 20.05.2023) Pursuant to Regulations 33, 30 and other applicable regulations, if any, of SEBI LODR, we would like to inform you that the Board of Directors of the Company at its meeting held today: a) Considered and approved the Audited Financial Statement (Standalone and Consolidated) for the quarter / year ended 31st March 2023 which are enclosed herewith along with the Auditors' Report on the Standalone and Consolidated Financial Statement. Bathiya & Associates, LLP, Statutory Auditors have issued Audit Reports with unmodified opinion on the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2023. b) Recommended Dividend of Rs.3.00 per equity share for the fy ended 31st March, 2023 subject to the approval of the members in the ensuing AGM. c) Re-appointed M/s. Bathiya and Associates LLP (Firm Registration No. 101046W/W100063) as Statutory Auditors of the Company for a term of five years, subject to approval of members at the ensuing AGM. (As per BSE Announcement Dated on 22/05/2023)
13-Jan-2023	21-Jan-2023	Quarterly Results	CHEMBOND CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2023 inter alia to consider and approve Pursuant to the provisions of Regulation 29 and other applicable regulations if any of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday 21st January 2023 inter-alia to consider approve and take on record the Unaudited Financial Results on Standalone and Consolidated basis for the quarter and nine months ended 31st December 2022 (Q3). Further pursuant to our letter Ref. No. SE/CS/2022-23/44 dated 29th December 2022 and in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of board meeting i.e. till 23rd January 2023. In continuation to our letter bearing Ref. no. SE/CS/2022-23/48 dated 13th January, 2023, and pursuant to Regulations 33, 30 and other applicable regulations, if any, of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (the Listing Regulations), we hereby inform you that the Board of Directors of the Company in its meeting held today considered and approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2022 which are enclosed, along with the Limited Review Report. The meeting of Audit Committee / Board of Directors of the Company commenced at 12.45 p.m. and concluded at 5.00 p.m. (As Per BSE Announcement Dated on 21/01/2023) Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the extract of the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2022 published in newspapers, The Business Standard (English) and Mumbai Lakshadeep (Marathi) on 23rd January, 2023. Please take the above information on record. (As Per BSE Announcement Dated on 23/01/2023) In furtherance to our letter dated 23rd January, 2023 with reference to captioned subject, please find enclosed herewith the newspaper cutting of the Corrigendum published in the Marathi newspaper Mumbai Lakshadweep on 24.01.2023. With reference to Unaudited Financial Results published in Lakshadweep newspaper on 23rd January, 2023 on page no. 5, the figure mentioned in the last column viz. year ended 31.03.2022 Audited of row with particulars Basic and diluted EPS below serial no. 8 was advertently written as 13.35 instead of 10.35 (correct number). The same has been clarified in the corrigendum. Please take the above information on record. (As Per BSE Announcement Dated on 24/01/2023)
10-Oct-2022	20-Oct-2022	Quarterly Results	CHEMBOND CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2022 inter alia to consider and approve Pursuant to the provisions of Regulation 29 and other applicable regulations if any of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Thursday 20th October 2022 inter-alia to consider approve and take on record the Unaudited Financial Results on Standalone and Consolidated basis for the quarter and half year ended 30th September 2022.. Further pursuant to our letter Ref. No. SE/CS/2022-23/33 dated 29th September 2022 and in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of board meeting i.e. till 22nd October 2022. In continuation to our letter bearing Ref. no. SE/CS/2022-23/35 dated 10th October, 2022, and pursuant to Regulations 33, 30 and other applicable regulations, if any, of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, (the Listing Regulations), we hereby inform you that the Board of Directors of the Company in its meeting held today; a) Considered and approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2022 which are enclosed, along with the Limited Review Report. The meeting of Audit Committee / Board of Directors of the Company commenced at 10.15 a.m. and concluded at 4.05 p.m. (As Per BSE Announcement Dated on 20/10/2022)
20-Jul-2022	29-Jul-2022	Quarterly Results	CHEMBOND CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2022 inter alia to consider and approve Pursuant to the provisions of Regulation 29 and other applicable regulations if any of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Friday 29th July 2022 inter-alia to consider approve and take on record the Unaudited Financial Results on Standalone and Consolidated basis for the quarter ended 30th June 2022 (Q1). Further pursuant to our letter Ref. No. SE/CS/2022-23/20 dated 30th June 2022 and in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of board meeting i.e. till 31st July 2022. Dear Sir / Madam, In continuation to our letter bearing Ref. no. SE/CS/2022-23/27 dated 20th July, 2022, and pursuant to Regulations 33, 30 and other applicable regulations, if any, of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, (the Listing Regulations), we hereby inform you that the Board of Directors of the Company in its meeting held today; a) Considered and approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2022 which are enclosed, along with the Limited Review Report. The meeting of Audit Committee / Board of Directors of the Company commenced at 10.15 a.m. and concluded at 03.55 p.m. (As per BSE Announcement Dated on 29/07/2022) Dear Sir / Madam, Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the extract of the Unaudited Financial Results of the Company for the quarter ended 30th June, 2022 published in newspapers, the Business Standard (English) and Mumbai Lakshadeep (Marathi) on 30th July, 2022. Please take the above information on record. (As Per BSE Announcement Dated on 30/07/2022)
04-May-2022	14-May-2022	Final Dividend	CHEMBOND CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2022 inter alia to consider and approve Pursuant to the provisions of Regulation 29 and other applicable regulations if any of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday 14th May 2022 inter-alia to consider approve and take on record the Audited Financial Results on Standalone and Consolidated basis for the quarter / year ended 31st March 2022. to recommend declaration of dividend for FY 2021-22 if any. Further pursuant to our letter Ref. No. SE/CS/2021-22/54 dated 30th March 2022 and in terms of SEBI (PIT) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of board meeting i.e. till 16th May 2022. The Trading window shall re-open on 17th May 2022. Chembond Chemicals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2022, inter alia, has recornmended Dividend of Rs. 5.00 (Rupees Five only) per equity share for the financial year ended March 31, 2022 subject to the approval of the members in the ensuing Annual General Meebing (AGM). The dividend will be paid within 30 days from the date of approval by the rnenbers at the ensuing AGM of the Company. In continuation to our letter bearing Ref. no. SE/CS/2022-23/12 dated 4th May, 2022, and pursuant to Regulations 33, 30 and other applicable regulations, if any, of the SEBI LODR Regulations, we have to inform you that the Board of Directors of the Company at its meeting held today, a) Considered and approved the Audited Financial Statement (Standalone and Consolidated) for the quarter / year ended 31st March 2022 which are enclosed herewith along with the Auditors' Report on the Standalone and Consolidated Financial Statement. Further, we would like to inform you that Bathiya & Associates, LLP, Chartered Accountants, Statutory Auditors have issued Audit Reports with unmodified opinion on the Audited Financial Results (Standalone and Consolidated) for the quarter and financial YE 31st March, 2022. b) Recommended Dividend of Rs.5.00 (Rupees Five only) per equity share for the financial year ended 31st March, 2022 subject to the approval of the members in the ensuing AGM. (As Per BSE Announcement Dated on 14.05.2022)
11-Jan-2022	19-Jan-2022	Quarterly Results	CHEMBOND CHEMICALS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/01/2022 inter alia to consider and approve We wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday 19th January 2022 inter-alia to consider approve and take on record the Unaudited Financial Results on Standalone and Consolidated basis for the quarter and nine months ended 31st December 2021 (Q3). Further pursuant to our letter Ref. No. SE/CS/2021-22/44 dated 30th December 2021 and in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of Board meeting i.e. till 21st January 2022. Please take the above information on record. In continuation to our letter bearing Ref. no. SE/CS/2021-22/46 dated 11th January, 2022, & pursuant to Regulations 33, 30 & other applicable regulations, if any, of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Board at its meeting held today: Considered & approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter & nine months ended 31st December, 2021 which are enclosed, along with the Limited Review Report. The meeting of Audit Committee/Board of Directors of the Company commenced at 10.45 a.m. & concluded at 02.50 p.m. Further, pursuant to our letter Ref. No. SE/CS/2021-22/44 dated 30th December, 2021 & in terms of SEBI (PIT) Regulations, 2015 & the Company's internal code of conduct, for prevention of Insider Trading, the Trading window for dealing in securities of the Company will remain closed for Directors / Officers / Designated persons of the Company till 48 hours post the outcome of board meeting i.e. till 21st January, 2022. In continuation to our letter bearing Ref. no. SE/CS/2021-22/46 dated 11th January, 2022 & pursuant to Regulations 33, 30 & other applicable regulations, if any, of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Board at its meeting held today: a) Considered & approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter & nine months ended 31st December, 2021 which are enclosed, along with the Limited Review Report. The meeting of Audit Committee /Board of Directors of the Company commenced at 10.45 a.m. & concluded at 02.50 p.m. Further, pursuant to our letter Ref. No. SE/CS/2021-22/44 dated 30th December, 2021 & in terms of SEBI (PIT) Regulations, 2015 & the Company's internal code of conduct, for prevention of Insider Trading, the Trading window for dealing in securities of the Company will remain closed for Directors/ Officers/ Designated persons of the Company till 48 hours post the outcome of board meeting i.e. till 21st January, 2022. (As Per BSE Announcement Dated on 19.01.2022)

1 2

LOGIN HERE

Chembond Chemicals Ltd

Board Meeting